Cargando…
An overview of diagnosis and management of drug‐induced hypomagnesemia
Magnesium (Mg) is commonly addressed as the “forgotten ion” in medicine. Nonetheless, hypomagnesemia should be suspected in clinical practice in patients with relevant symptomatology and also be considered a predisposing factor for the development of other electrolyte disturbances. Furthermore, chro...
Autores principales: | Liamis, George, Hoorn, Ewout J., Florentin, Matilda, Milionis, Haralampos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287009/ https://www.ncbi.nlm.nih.gov/pubmed/34278747 http://dx.doi.org/10.1002/prp2.829 |
Ejemplares similares
-
A review of drug-induced hypernatraemia
por: Liamis, George, et al.
Publicado: (2009) -
A step-by-step guide for the diagnosis and management of hyponatraemia in
patients with stroke
por: Barkas, Fotios, et al.
Publicado: (2023) -
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2023) -
Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020) -
Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia
por: Parthymos, Ioannis, et al.
Publicado: (2022)